Skip to main content

Investing

By Dave Muoio | 12:19 pm | January 07, 2021
While equity investments in telemedicine rose 139% to $4.3 billion, other areas like data analytics and mobile health apps also earned strong support from investors.
By Tammy Lovell | 02:58 am | January 06, 2021
The funds will be used to drive European leadership in digital chronic disease prevention and management.
By Laura Lovett | 12:28 pm | January 05, 2021
The company is using the new funds to hire more staff in leadership positions. 
By Dave Muoio | 12:19 pm | January 05, 2021
The SaaS company specializes in reputation management and targeted marketing for doctors, practices and healthcare organizations.
By Sara Mageit | 06:23 am | January 05, 2021
The company will use the funding to expand its teledermatology services and 600 specialists in the DACH region.
By Laura Lovett | 02:23 pm | January 04, 2021
Sequoia Capital and NewView Capital participated in the latest funding round. 
By Dave Muoio | 12:28 pm | January 04, 2021
The nearly 20-year-old brand started as an online hub for providers, but now hosts consumer-facing resources and in-person health clinics.
By Dave Muoio | 04:20 pm | November 05, 2020
The company's lead offering for employer customers has so far reached more than 250,000 users.
By Laura Lovett | 04:20 pm | November 05, 2020
The company attributed much of its success to growing smartwatch sales. 
By Mallory Hackett | 01:13 pm | November 05, 2020
With the creation of digital twins in studies, Unlearn generates an intelligent control arm that can reduce the sample size and decrease the number of participants given the placebo.